A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New Infant- and Follow-on Formula for Healthy Term Infants.

Inclusion Criteria:

• Healthy, singleton, term born infants (gestational age ≥ 37 weeks + 0 days and ≤ 41weeks + 6 days).

• Infants aged ≤ 14 days at enrolment.

• Weight at birth within 10th to 90th percentile per gestational age and sex,according to Intergrowth Standards

• For formula feeding groups: Infants fully formula fed at the time of enrolment.

• For breastfed reference group: Infants exclusively breastfed at the time ofenrolment and parent(s) intend to exclusively breastfeed the infant at least until 16 weeks after Visit 1.

• Written informed consent (IC) from parent(s) and/or legally acceptablerepresentative(s) aged ≥18 years at enrolment.

Exclusion Criteria:

• . Infants who require a special diet other than IF with intact cow's milk protein.

• Infants known or suspected to have cow's milk, fish, and/or soy allergy and/orlactose intolerance.

• Infants with current or previous illnesses/conditions and/or known or suspectedcongenital diseases or malformations which could interfere with the study outcomes,as per investigator's clinical judgement.

• Infants whose mother is known to suffer from an illness or condition which couldinterfere with the study outcomes, as per investigator's clinical judgement.

• Infants with previous, current, or intended participation in any concomitantclinical study involving investigational or marketed products.

• Investigator's uncertainty about the willingness or ability of parents or legallyacceptable representative(s) to comply with the protocol requirements.